Literature DB >> 8588235

Lake Louise Consensus Conference on cyclosporin monitoring in organ transplantation: report of the consensus panel.

M Oellerich1, V W Armstrong, B Kahan, L Shaw, D W Holt, R Yatscoff, A Lindholm, P Halloran, K Gallicano, K Wonigeit.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8588235     DOI: 10.1097/00007691-199512000-00017

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


× No keyword cloud information.
  20 in total

Review 1.  Therapeutic drug monitoring of immunosuppressant drugs.

Authors:  A Johnston; D W Holt
Journal:  Br J Clin Pharmacol       Date:  1999-04       Impact factor: 4.335

2.  Bayesian estimation of cyclosporin exposure for routine therapeutic drug monitoring in kidney transplant patients.

Authors:  Hélène Bourgoin; Gilles Paintaud; Matthias Büchler; Yvon Lebranchu; Elisabeth Autret-Leca; France Mentré; Chantal Le Guellec
Journal:  Br J Clin Pharmacol       Date:  2005-01       Impact factor: 4.335

Review 3.  A role for cytokine measurement in therapeutic monitoring of immunosuppressive drugs following lung transplantation.

Authors:  P A Corris; J A Kirby
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

Review 4.  The use of therapeutic drug monitoring to optimise immunosuppressive therapy.

Authors:  S M Tsunoda; F T Aweeka
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

5.  Conversion of cardiac and liver transplant recipients from HPLC and FPIA (polyclonal) to an FPIA (monoclonal) technique for measurement of blood cyclosporin A.

Authors:  J H McBride; S Kim; D O Rodgerson; A Reyes
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

Review 6.  Target concentration strategy for cyclosporin monitoring.

Authors:  R G Morris
Journal:  Clin Pharmacokinet       Date:  1997-03       Impact factor: 6.447

7.  Maximum a posteriori Bayesian estimation of oral cyclosporin pharmacokinetics in patients with stable renal transplants.

Authors:  Frédéric Leger; Jean Debord; Yann Le Meur; Annick Rousseau; Mathias Büchler; Gérard Lachâtre; Gilles Paintaud; Pierre Marquet
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 8.  Immunosuppressive therapy for paediatric transplant patients: pharmacokinetic considerations.

Authors:  María del Mar Fernández De Gatta; Dolores Santos-Buelga; Alfonso Domínguez-Gil; María José García
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

9.  Cyclosporin therapeutic drug monitoring--an established service revisited.

Authors:  Raymond G Morris
Journal:  Clin Biochem Rev       Date:  2003-05

10.  An economic model of 2-hour post-dose ciclosporin monitoring in renal transplantation.

Authors:  Paul A Keown; Bryce Kiberd; Robert Balshaw; Shideh Khorasheh; Carlo Marra; Philip Belitsky; Zoltan Kalo
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.